Pharma Pulse: US Manufacturing Expansion, Oncology Partnerships, and Workplace Health

Dec 23, 2025, 10:30 AM
Headliner
Share
Subscribe
In today’s Pharma Pulse, Samsung Biologics enters the US market with a $280 million site acquisition, AstraZeneca secures a multi-billion-dollar cancer deal, and new research identifies occupational drivers of long COVID.
Share
Subscribe
Next
Pharma Pulse: FDA Clears First Oral Wegovy; Yusen Logistics Seals European Health Deal
Top episodes
Overcoming Supply Chain Challenges
by Pharmaceutical Commerce
Incorporating AI into Commercialization Plans
by Pharmaceutical Commerce
The Capabilities of a 3PL Provider
by Pharmaceutical Commerce